NEUROHELP
General Data
Reg Number
516272226
Sector
Medical Devices
Established
2018
No. of Employees
15
Stage
R&D
Additional Funding
1
Description
A cutting-edge AI-driven digital health startup, focuses on the 1% of the global population living with epilepsy. Our pioneer system detects and predicts epileptic seizures up to an hour before they occur, utilizing advanced AI techniques and proprietary
Technology
Epiness™ integrates algorithms for real-time seizure prediction and detection on time scales of minutes to hours in advance. The system is equipped with eight EEG sensors and augmented with integrated sensors for motion, temperature, and heart activity. NeuroHelp's unique core technology is algorithm-based and incorporates advanced measures of brain activity that reflect the underlying dynamics. By integrating these measures with machine and deep learning techniques, the company's algorithms can uncover intricate patterns associated with distinct dynamical states, thereby facilitating accurate seizure prediction, detection, and comprehensive epilepsy diagnosis
Targeted Customers
People with epilepsy and their care givers, HMO's, Clinics.
Management personnel
Winning details
Route name
Winning year
R&D Fund
R&D Fund
2024
R&D Program second/third year request for Entitled Growth Corporate
R&D Program second/third year request for Entitled Growth Corporate
2023